New York, NY -- (SBWIRE) -- 12/06/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: North American Oil & Gas Corp (OTCBB:NAMG), Authentidate Holding Corp (NASDAQ:ADAT), Arena Pharmaceuticals, Inc (NASDAQ:ARNA), Advanced Micro Devices, Inc (NYSE:AMD)
North American Oil & Gas Corp (OTCBB:NAMG) showed a volume of 623,396.00 shares by the end of last trade whereas the average volume of the stock remained 627,122.00 shares. The stock opened the session at $0.89 but then moved to $0.845. At that price, the stock showed a negative performance of -6.11%. North American Oil & Gas Corp. (NAMOG) is a development-stage company. The Company is engaged in oil and gas exploration in California, through its subsidiary Lani. The Company is focused on its oil and natural gas exploration, exploitation and development operations on projects located in the San Joaquin Basin, California; its Tejon Main prospect,
Will NAMG Get Buyers Even After The Recent Rally? Find Out Here
Authentidate Holding Corp (NASDAQ:ADAT) opened the session at $1.54 and closed the session at $1.76. The stock showed a positive performance of 18.92% in previous trading session. Authentidate Holding Corp. (Authentidate) is a provider of Web-based software applications and telehealth products and services that enable healthcare organizations to coordinate care for patients and enhance related administrative and clinical workflows. The Company and its subsidiaries provide software applications and Web-based services that address a variety of business needs for its customers.
For How Long ADAT will fight for Profitability? Read This Trend Analysis report
Arena Pharmaceuticals, Inc (NASDAQ:ARNA) opened the session at $6.49 and closed the session at $6.20. The stock showed a negative performance of -5.05% in previous trading session. The beta of the stock remained -0.39. Arena Pharmaceuticals, Inc. (Arena) is a biopharmaceutical company focused on discovering, developing and commercializing drugs that target G protein-coupled receptors. Its wholly owned subsidiary, Arena Pharmaceuticals GmbH (Arena GmbH), has granted Eisai Inc., rights to commercialize BELVIQ in the United States.
Why Should Investors Buy ARNA After the Recent Fall? Just Go Here and Find Out
Advanced Micro Devices, Inc (NYSE:AMD) the stock advanced 1.96% and finished the session at $3.64. Traded with volume of 14.46 million shares in the prior session and the average volume of the stock remained 20.25 million shares. The beta of the stock remained 2.21. Advanced Micro Devices, Inc. (AMD) is a global semiconductor company with facilities around the world. The Company offers x86 microprocessors, as standalone devices or as incorporated as an accelerated processing unit (APU), for the commercial and consumer markets, embedded microprocessors for commercial, commercial client and consumer markets and chipsets for desktop and mobile devices, including mobile personal computers, or PCs, and tablets, professional workstations and servers and graphics,
Will AMD Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)